181 related articles for article (PubMed ID: 18421716)
1. Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma.
Jain N; Krull KR; Brouwers P; Chintagumpala MM; Woo SY
Pediatr Blood Cancer; 2008 Aug; 51(2):275-9. PubMed ID: 18421716
[TBL] [Abstract][Full Text] [Related]
2. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
Paulino AC; Lobo M; Teh BS; Okcu MF; South M; Butler EB; Su J; Chintagumpala M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1445-50. PubMed ID: 20231075
[TBL] [Abstract][Full Text] [Related]
3. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
4. Language skills following risk-adapted treatment for medulloblastoma.
Lewis F; Murdoch B
Dev Neurorehabil; 2010; 13(3):217-24. PubMed ID: 20450472
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive function in same-sex twins following focal radiation for medulloblastoma.
Mabbott DJ; Barnes M; Laperriere N; Landry SH; Bouffet E
Neuro Oncol; 2007 Oct; 9(4):460-4. PubMed ID: 17704358
[TBL] [Abstract][Full Text] [Related]
6. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.
St Clair WH; Adams JA; Bues M; Fullerton BC; La Shell S; Kooy HM; Loeffler JS; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):727-34. PubMed ID: 14967427
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
Huang E; Teh BS; Strother DR; Davis QG; Chiu JK; Lu HH; Carpenter LS; Mai WY; Chintagumpala MM; South M; Grant WH; Butler EB; Woo SY
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):599-605. PubMed ID: 11849779
[TBL] [Abstract][Full Text] [Related]
8. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
Paulino AC; Mazloom A; Teh BS; South M; Okcu MF; Su J; Butler EB; Chintagumpala M
Cancer; 2011 Feb; 117(3):635-41. PubMed ID: 20845476
[TBL] [Abstract][Full Text] [Related]
9. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.
Palmer SL; Gajjar A; Reddick WE; Glass JO; Kun LE; Wu S; Xiong X; Mulhern RK
Neuropsychology; 2003 Oct; 17(4):548-55. PubMed ID: 14599268
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
Cancer; 2005 Feb; 103(4):793-801. PubMed ID: 15637691
[TBL] [Abstract][Full Text] [Related]
11. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma.
Hardy KK; Bonner MJ; Willard VW; Watral MA; Gururangan S
Psychooncology; 2008 Nov; 17(11):1157-61. PubMed ID: 18636431
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review.
Vieira WA; Weltman E; Chen MJ; da Silva NS; Cappellano AM; Pereira LD; Gonçalves MI; Ferrigno R; Hanriot RM; Nadalin W; Odone Filho V; Petrilli AS
Radiat Oncol; 2014 Jul; 9():158. PubMed ID: 25041714
[TBL] [Abstract][Full Text] [Related]
13. Early patterns of verbal memory impairment in children treated for medulloblastoma.
Nagel BJ; Delis DC; Palmer SL; Reeves C; Gajjar A; Mulhern RK
Neuropsychology; 2006 Jan; 20(1):105-12. PubMed ID: 16460226
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure in children with medulloblastoma treated with 3D conformal radiotherapy.
Skowrońska-Gardas A; Chojnacka M; Morawska-Kaczyńska M; Perek D; Perek-Polnik M
Radiother Oncol; 2007 Jul; 84(1):26-33. PubMed ID: 17560676
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a new noncoplanar intensity-modulated radiation therapy technique for craniospinal irradiation with 3 coplanar techniques.
Hansen AT; Lukacova S; Lassen-Ramshad Y; Petersen JB
Med Dosim; 2015; 40(4):296-303. PubMed ID: 26002123
[TBL] [Abstract][Full Text] [Related]
17. Outcome of medulloblastoma in children: long-term complications and quality of life.
Ribi K; Relly C; Landolt MA; Alber FD; Boltshauser E; Grotzer MA
Neuropediatrics; 2005 Dec; 36(6):357-65. PubMed ID: 16429375
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
[TBL] [Abstract][Full Text] [Related]
19. Loss of fine motor function correlates with ataxia and decline of cognition in cerebellar tumor survivors.
Rueckriegel SM; Blankenburg F; Henze G; Baqué H; Driever PH
Pediatr Blood Cancer; 2009 Sep; 53(3):424-31. PubMed ID: 19484752
[TBL] [Abstract][Full Text] [Related]
20. The risk of secondary cancer in pediatric medulloblastoma patients due to three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.
Sherif RS; Elshemey WM; Attalla EM
Indian J Cancer; 2018; 55(4):372-376. PubMed ID: 30829273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
